| P50 | author | Allan Flyvbjerg | Q49252518 |
| P2093 | author name string | Nielsen B | |
| P2860 | cites work | Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence | Q33675668 |
| | Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group | Q34734009 |
| | Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy | Q34753900 |
| | Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis | Q35824836 |
| | Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection | Q41085449 |
| | Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. | Q42543650 |
| | The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension | Q44611131 |
| | Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. | Q44901316 |
| | Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. | Q51570195 |
| | Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients | Q57704352 |
| | Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment | Q61948419 |
| | Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria | Q62775829 |
| | Nifedipine versus fosinopril in uninephrectomized diabetic rats | Q67547021 |
| | Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy | Q67913576 |
| | Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus | Q68458135 |
| | Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial | Q69340480 |
| | Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy | Q70254346 |
| | Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria | Q70462194 |
| | The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 |
| | Effects of nisoldipine on hypertension and glomerulosclerosis in Cohen diabetic rat with Goldblatt hypertension | Q70645810 |
| | Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms | Q70673075 |
| | Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats | Q70734589 |
| | Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients | Q70869252 |
| | Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes | Q71216958 |
| | Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy | Q71769802 |
| | Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes | Q72201091 |
| | A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension | Q72398845 |
| | Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats | Q72535092 |
| | Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs | Q72735542 |
| | Comparative effects of different antihypertensive treatments on progression of diabetic renal disease | Q72967212 |
| | Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans | Q73115386 |
| | Renal effects of antihypertensive therapy in uninephrectomized diabetic rats | Q74080676 |
| | Calcium-channel blockers for hypertension--uncertainty continues | Q74257887 |
| | Calcium antagonists and renal disease | Q77650727 |
| | The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats | Q77823839 |
| | Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion | Q78036451 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 581-585 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview | |
| P478 | volume | 15 | |